This inventor holds 2 USPTO granted patents. Top assignee: Cell Therapeutics, Inc.. Active years: 1999-2001.
Company Filing History:
Years Active: 1999-2001
Title: Reitha Weeks: Innovator in Mammalian Metabolism
Introduction
Reitha Weeks is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of biochemistry, particularly in the area of phosphatidic acid metabolism. With a total of 2 patents, her work has implications for understanding cellular signaling processes in mammalian cells.
Latest Patents
Reitha Weeks holds patents related to Mammalian CDP-diacylglycerol synthase. These patents disclose cDNA sequences and polypeptides that exhibit the enzyme CDP-diacylglycerol synthase (CDS) activity, also known as CTP:phosphatidate cytidylyltransferase. The patents further detail methods for the isolation and production of polypeptides involved in phosphatidic acid metabolism and signaling in mammalian cells. This includes the production of purified forms of CDS, which is crucial for advancing research in this area.
Career Highlights
Reitha is currently associated with Cell Therapeutics, Inc., where she continues to innovate and contribute to the field. Her work is instrumental in developing therapeutic strategies that leverage her discoveries in enzyme activity and cellular processes.
Collaborations
Reitha collaborates with various professionals in her field, including her coworker David W. Leung. Their combined expertise enhances the research and development efforts at Cell Therapeutics, Inc.
Conclusion
Reitha Weeks is a notable inventor whose work in mammalian metabolism has led to valuable patents and advancements in biochemistry. Her contributions continue to influence the scientific community and pave the way for future innovations.